KENVUE INC. overview

Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio NORTHAMPTON, MA / ACCESS Newswire / June 26, 2025 / Kenvue Inc. (NYSE:KVUE), maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol® , today released its second Healthy Lives Mission Report. The report shares how Kenvue has helped advance the well-being of both people and planet in 2024, with progress noted...

First Task Force on Climate-related Financial Disclosures (TCFD) report enhances transparency and accountability Company advances sustainability across its products, operations and value chain as part of its Healthy Lives Mission Progress includes reducing Scope 1 and 2 greenhouse gas emissions 1, 2, 3 by 26% since 2020 and increasing renewable electricity 4 usage to 65% of its electricity usage SKILLMAN, NJ / ACCESSWIRE / September 23, 2024 / Kenvue Inc. (NYSE:KVUE) ("Kenvue" or the "Company"),...

Maker of iconic brands such as Neutrogena®, Listerine®, Aveeno® and Tylenol® shares progress on its Environmental, Social and Governance goals in first year as an independent company. SKILLMAN, NJ / ACCESSWIRE / June 25, 2024 / Kenvue Inc. (NYSE:KVUE) ("Kenvue" or the "Company"), the world's largest pure-play consumer health company by revenue, today released its first-ever Healthy Lives Mission Report and shared how the Company advanced the well-being of both people and planet in 2023. "We...

Maker of iconic brands such as Neutrogena®, Listerine®, Aveeno® and Tylenol® aims to advance the well-being of people and planet through its Healthy Lives Mission SKILLMAN, NJ / ACCESSWIRE / May 2, 2024 / Kenvue Inc. (NYSE:KVUE) ("Kenvue" or the "Company"), the world's largest pure-play consumer health company by revenue, today announced that its near-term greenhouse gas (GHG) emissions reduction targets have been validated by the Science Based Targets initiative (SBTi). SBTi has validated...

LOS ANGELES, CA / ACCESSWIRE / December 5, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "the Company") (NYSE:KVUE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's May 2023 initial public offering ("IPO"), are encouraged to contact the firm before December 8, 2023. If you are a shareholder who...

LOS ANGELES, CA / ACCESSWIRE / November 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "the Company") (NYSE:KVUE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's May 2023 initial public offering ("IPO"), are encouraged to contact the firm before December 8, 2023. If you are a shareholder who...

LOS ANGELES, CA / ACCESSWIRE / October 8, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kenvue Inc. ("Kenvue" or "the Company") (NYSE:KVUE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. If you are a shareholder who suffered a loss, click here to...